LUNG
LUNG clinical trials: Pulmonx Corp
Every trial on ClinicalTrials.gov where Pulmonx Corp is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 17
- Trials linked
- 15
- As lead sponsor
- 2
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
LUNG on the catalyst calendar · LUNG registry changes
- Primary completion Mar 31, 2027Sponsor estimateNo phase registeredNCT06332885Zephyr Valve Japan Post-Marketing SurveillancePulmonx Corporation · EmphysemaRecruitingLUNGLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 30, 2027Sponsor estimateNo phase registeredNCT06035120An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe EmphysemaPulmonx Corporation · Emphysema, PulmonaryRecruitingLUNGLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2026Sponsor estimateNo phase registeredNCT04186546Zephyr Valve Registry (ZEVR)Pulmonx Corporation · EmphysemaActive, not recruitingLUNGLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 22, 2022ActualNo phase registeredNCT04517916Zephyr Etude Post-Inscription (French Registry)Pulmonx Corporation · Emphysema or COPDCompletedLUNGLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 5, 2024ActualNo phase registeredNCT04465461Video Assisted Thoracic Surgery (VATS) Fissure Completion Prior to Zephyr® Endobronchial Valve InsertionPulmonx Corporation · Pulmonary EmphysemaCompletedLUNGLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 24, 2023ActualNo phase registeredNCT04559464Fissure Closure With the AeriSeal System for CONVERTing Collateral Ventilation Status (CONVERT)Pulmonx Corporation · EmphysemaCompletedLUNGLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 13, 2021ActualNo phase registeredNCT04161235Post-Market Clinical Evaluation of the Zephyr Valve 5.5-LP EBVPulmonx Corporation · Pulmonary EmphysemaCompletedLUNGLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2017ActualNo phase registeredNCT01796392Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)Pulmonx Corporation · EmphysemaCompletedLUNGLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2016ActualNo phase registeredNCT02025205Improving Patient Outcomes by Selective Implantation of the Zephyr EBV - StudyPulmonx International Sàrl · COPD Patients With Homogeneous EmphysemaCompletedLUNGLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 20, 2017ActualNo phase registeredNCT02022683To Improve Lung Function and Symptoms for Emphysema Patients Using Zephyr ValvesPulmonx Corporation · COPDCompletedLUNGLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 16, 2017ActualNo phase registeredNCT02877459Clinical Investigation of a Modified Staged Treatment Algorithm Using the AeriSeal SystemPulmonx Corporation · EmphysemaCompletedLUNGLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2016ActualNo phase registeredNCT01580215Long Term Follow up Investigation of Endobronchial Valves in EmphysemaPulmonx International Sàrl · Pulmonary EmphysemaTerminatedLUNGLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2013ActualNo phase registeredNCT01101958A Study of the Use of Chartis System to Optimize Subject Selection for Endobronchial Lung Volume Reduction (ELVR)Pulmonx Corporation · EmphysemaCompletedLUNGLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2008ActualPhase 1/Phase 2NCT00684892Safety and Feasibility Study of the Chartis System With Heterogeneous Emphysema Prior to Endobronchial Lung Volume Reduction (ELVR)Pulmonx Corporation · Heterogeneous EmphysemaCompletedLUNGLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2008ActualPhase 1NCT00684684Safety and Feasibility Study of the Chartis SystemPulmonx Corporation · BronchoscopyCompletedLUNGLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2026Sponsor estimateNo phase registeredNCT04801108Combined Zephyr Valve System With Inter-lobar Fissure Completion for Lung Volume Reduction in EmphysemaBeth Israel Deaconess Medical Center · Emphysema or COPDActive, not recruitingLUNGCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 31, 2022ActualNo phase registeredNCT04256408Mind The Gap - Crossing Borders StudyUniversity Medical Center Groningen · EmphysemaCompletedLUNGCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 17 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner